Type 2 diabetes
Conditions
Interventions
Observation Group:None
Sponsors
Zhejiang Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Age 18 to 75 years; 2. Clearly diagnosed with type 2 diabetes according to the 'Chinese Diabetes Prevention and Treatment Guidelines (2024 Edition)', with HbA1c levels between 7.0% and 10.5%; 3. Meeting the treatment indications of the drug Metformin; 4. Signing the informed consent form to voluntarily participate in the study.
Exclusion criteria
Exclusion criteria: 1. Patients with severe heart failure (NYHA Class III-IV), liver dysfunction (ALT or AST exceeding 3 times the normal upper limit), and acute renal failure; 2. Those currently or recently suffering from acute infections, severe injuries, or recovery periods from surgeries that affect metabolic status; 3. Patients with concurrent malignant tumors or other serious diseases affecting prognosis and compliance; 4. Individuals using medications affecting glucose metabolism, such as systemic corticosteroids and immunosuppressants; 5. Pregnant or breastfeeding women, or those planning to become pregnant during the study; 6. Individuals with mental or neurological diseases affecting their judgment, or those unable to cooperate with follow-ups and sample collection.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood glucose;Hemoglobin A1c (HbA1c);Glycated Albumin (GA);Glucokinase activity;Infrared Spectroscopy Detection; | — |
Secondary
| Measure | Time frame |
|---|---|
| Liver Function;Renal Function; | — |
Countries
China
Contacts
Public ContactDan Yu
Zhejiang Hospital
Outcome results
None listed